Indefinite Delivery Contract SPE2DR25D9339

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The $499,999,999 IDC, valid through November 2026, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract enables the DLA to issue firm fixed-price delivery orders for the procurement of these pharmaceutical items to meet the medical supply requirements of Department of Defense (DoD) healthcare sites globally, including during planned and unplanned contingency operations. The IDC was awarded as a result of a pre-solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts, which the DLA Troop Support plans to issue in March 2024 as an unrestricted, fully competitive acquisition with the intent to make multiple regional awards.